|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Funk GF, Karnell LH, Robinson RA, Zhen WK,
Trask DK and Hoffman HT: Presentation, treatment, and outcome of
oral cavity cancer: A National Cancer Data Base report. Head Neck.
24:165–180. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Croce CM: Oncogenes and cancer. N Engl J
Med. 358:502–511. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karp X and Ambros V: Developmental
biology. Encountering microRNAs in cell fate signaling. Science.
310:1288–1289. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang CN, Deng YT, Tang JY, Cheng SJ, Chen
ST, Li YJ, Wu TS, Yang MH, Lin BR, Kuo MY, et al: MicroRNA-29b
regulates migration in oral squamous cell carcinoma and its
clinical significance. Oral Oncol. 51:170–177. 2015. View Article : Google Scholar
|
|
7
|
Yu T, Liu K, Wu Y, Fan J, Chen J, Li C,
Yang Q and Wang Z: MicroRNA-9 inhibits the proliferation of oral
squamous cell carcinoma cells by suppressing expression of CXCR4
via the Wnt/β-catenin signaling pathway. Oncogene. 33:5017–5027.
2014. View Article : Google Scholar
|
|
8
|
Lu L, Xue X, Lan J, Gao Y, Xiong Z, Zhang
H, Jiang W, Song W and Zhi Q: MicroRNA-29a upregulates MMP2 in oral
squamous cell carcinoma to promote cancer invasion and
anti-apoptosis. Biomed Pharmacother. 68:13–19. 2014. View Article : Google Scholar
|
|
9
|
Mitra D, Das PM, Huynh FC and Jones FE:
Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle
progression through epigenetic repression of microRNA let-7e. J
Biol Chem. 286:40531–40535. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu WY, Luo B, An JY, He JY, Chen DD, Xu
LY, Huang YY, Liu XG, Le HB and Zhang YK: Differential expression
of miR-125a-5p and let-7e predicts the progression and prognosis of
non-small cell lung cancer. Cancer Invest. 32:394–401. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ninio-Many L, Grossman H, Levi M, Zilber
S, Tsarfaty I, Shomron N, Tuvar A, Chuderland D, Stemmer SM,
Ben-Aharon I, et al: MicroRNA miR-125a-3p modulates molecular
pathway of motility and migration in prostate cancer cells.
Oncoscience. 1:250–261. 2014.
|
|
12
|
Jiang L, Huang Q, Zhang S, Zhang Q, Chang
J, Qiu X and Wang E: Hsa-miR-125a-3p and hsa-miR-125a-5p are
downregulated in non-small cell lung cancer and have inverse
effects on invasion and migration of lung cancer cells. BMC Cancer.
10:3182010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
O'Day E and Lal A: MicroRNAs and their
target gene networks in breast cancer. Breast Cancer Res.
12:2012010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang H, Kim N, Park JH, Nam RH, Choi YJ,
Lee HS, Yoon H, Shin CM, Park YS, Kim JM, et al: Different microRNA
expression levels in gastric cancer depending on Helicobacter
pylori infection. Gut Liver. 9:188–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dettmer M, Perren A, Moch H, Komminoth P,
Nikiforov YE and Nikiforova MN: Comprehensive MicroRNA expression
profiling identifies novel markers in follicular variant of
papillary thyroid carcinoma. Thyroid. 23:1383–1389. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
17
|
Grassilli E, Narloch R, Federzoni E,
Ianzano L, Pisano F, Giovannoni R, Romano G, Masiero L, Leone BE,
Bonin S, et al: Inhibition of GSK3B bypass drug resistance of
p53-null colon carcinomas by enabling necroptosis in response to
chemotherapy. Clin Cancer Res. 19:3820–3831. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lai KW, Koh KX, Loh M, Tada K, Subramaniam
MM, Lim XY, Vaithilingam A, Salto-Tellez M, Iacopetta B, Ito Y, et
al; Singapore Gastric Cancer Consortium. MicroRNA-130b regulates
the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer.
46:1456–1463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Talbot SG, Estilo C, Maghami E, Sarkaria
IS, Pham DK, O-charoenrat P, Socci ND, Ngai I, Carlson D, Ghossein
R, et al: Gene expression profiling allows distinction between
primary and metastatic squamous cell carcinomas in the lung. Cancer
Res. 65:3063–3071. 2005.PubMed/NCBI
|
|
20
|
Estilo CL, O-charoenrat P, Talbot S, Socci
ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y,
Boyle JO, et al: Oral tongue cancer gene expression profiling:
Identification of novel potential prognosticators by
oligonucleotide microarray analysis. BMC Cancer. 9:112009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ye H, Yu T, Temam S, Ziober BL, Wang J,
Schwartz JL, Mao L, Wong DT and Zhou X: Transcriptomic dissection
of tongue squamous cell carcinoma. BMC Genomics. 9:692008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuriakose MA, Chen WT, He ZM, Sikora AG,
Zhang P, Zhang ZY, Qiu WL, Hsu DF, McMunn-Coffran C, Brown SM, et
al: Selection and validation of differentially expressed genes in
head and neck cancer. Cell Mol Life Sci. 61:1372–1383. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Toruner GA, Ulger C, Alkan M, Galante AT,
Rinaggio J, Wilk R, Tian B, Soteropoulos P, Hameed MR, Schwalb MN,
et al: Association between gene expression profile and tumor
invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet.
154:27–35. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peng CH, Liao CT, Peng SC, Chen YJ, Cheng
AJ, Juang JL, Tsai CY, Chen TC, Chuang YJ, Tang CY, et al: A novel
molecular signature identified by systems genetics approach
predicts prognosis in oral squamous cell carcinoma. PLoS One.
6:e234522011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tiwari A, Shivananda S, Gopinath KS and
Kumar A: MicroRNA-125a reduces proliferation and invasion of oral
squamous cell carcinoma cells by targeting estrogen-related
receptor α: Implications for cancer therapeutics. J Biol Chem.
289:32276–32290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shao Y, Qu Y, Dang S, Yao B and Ji M:
MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by
targeting c-Myc and Cdk6. Cancer Cell Int. 13:512013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu C, Wang Z, Wang Y and Gu W: MiR-338
suppresses the growth and metastasis of OSCC cells by targeting
NRP1. Mol Cell Biochem. 398:115–122. 2015. View Article : Google Scholar
|
|
28
|
Kang J, Lee SY, Lee SY, Kim YJ, Park JY,
Kwon SJ, Na MJ, Lee EJ, Jeon HS and Son JW: microRNA-99b acts as a
tumor suppressor in non-small cell lung cancer by directly
targeting fibroblast growth factor receptor 3. Exp Ther Med.
3:149–153. 2012.PubMed/NCBI
|
|
29
|
Wei F, Liu Y, Guo Y, Xiang A, Wang G, Xue
X and Lu Z: miR-99b-targeted mTOR induction contributes to
irradiation resistance in pancreatic cancer. Mol Cancer. 12:812013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jope RS and Johnson GV: The glamour and
gloom of glycogen synthase kinase-3. Trends Biochem Sci. 29:95–102.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cao Q, Lu X and Feng YJ: Glycogen synthase
kinase-3β positively regulates the proliferation of human ovarian
cancer cells. Cell Res. 16:671–677. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ougolkov AV, Fernandez-Zapico ME, Savoy
DN, Urrutia RA and Billadeau DD: Glycogen synthase kinase-3beta
participates in nuclear factor kappaB-mediated gene transcription
and cell survival in pancreatic cancer cells. Cancer Res.
65:2076–2081. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ougolkov AV, Fernandez-Zapico ME, Bilim
VN, Smyrk TC, Chari ST and Billadeau DD: Aberrant nuclear
accumulation of glycogen synthase kinase-3beta in human pancreatic
cancer: Association with kinase activity and tumor
dedifferentiation. Clin Cancer Res. 12:5074–5081. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Polakis P: The many ways of Wnt in cancer.
Curr Opin Genet Dev. 17:45–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kang T, Wei Y, Honaker Y, Yamaguchi H,
Appella E, Hung MC and Piwnica-Worms H: GSK-3 β targets Cdc25A for
ubiquitin-mediated proteolysis, and GSK-3 β inactivation correlates
with Cdc25A overproduction in human cancers. Cancer Cell. 13:36–47.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Perkins ND: The diverse and complex roles
of NF-κB subunits in cancer. Nat Rev Cancer. 12:121–132.
2012.PubMed/NCBI
|
|
37
|
Johnson J, Shi Z, Liu Y and Stack MS:
Inhibitors of NF-kappaB reverse cellular invasion and target gene
upregulation in an experimental model of aggressive oral squamous
cell carcinoma. Oral Oncol. 50:468–477. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takada Y, Ichikawa H, Pataer A, Swisher S
and Aggarwal BB: Genetic deletion of PKR abrogates TNF-induced
activation of IkappaBalpha kinase, JNK, Akt and cell proliferation
but potentiates p44/p42 MAPK and p38 MAPK activation. Oncogene.
26:1201–1212. 2007. View Article : Google Scholar
|
|
40
|
Wang L, Kang F, Li J, Zhang J and Shan B:
Overexpression of p65 attenuates celecoxib-induced cell death in
MDA-MB-231 human breast cancer cell line. Cancer Cell Int.
13:142013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tran KQ, Tin AS and Firestone GL:
Artemisinin triggers a G1 cell cycle arrest of human Ishikawa
endometrial cancer cells and inhibits cyclin-dependent kinase-4
promoter activity and expression by disrupting nuclear factor-κB
transcriptional signaling. Anticancer Drugs. 25:270–281. 2014.
View Article : Google Scholar :
|
|
42
|
Iwanaga R, Ozono E, Fujisawa J, Ikeda MA,
Okamura N, Huang Y and Ohtani K: Activation of the cyclin D2 and
cdk6 genes through NF-kappaB is critical for cell-cycle progression
induced by HTLV-I Tax. Oncogene. 27:5635–5642. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ho A and Dowdy SF: Regulation of G(1)
cell-cycle progression by oncogenes and tumor suppressor genes.
Curr Opin Genet Dev. 12:47–52. 2002. View Article : Google Scholar : PubMed/NCBI
|
